ArticleScientific reports2026
DFT investigation of hydroxyl radical scavenging mechanisms in bioactive terpenoids from Syzygium nervosum.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- DFT Investigation of 4-Mercaptoimidazole-Copper(I/II) Redox Chemistry and C2-Substituent Effects: A Minimal Scaffold Study of Ovothiol-Type Redox Cycling.Molecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reactive oxygen species, particularly the hydroxyl radical ([Formula: see text]), drive oxidative stress and cellular damage. This study employs density functional theory (M06-2X/def2-TZVP//M06-2X/ma-def2-SVP with SMD solvation) to identify the most promising antioxidant compounds from thirteen terpenoids isolated from Syzygium nervosum. Radical adduct formation (RAF) emerges as the dominant scavenging mechanism with low kinetic barriers (14-49 kJ/mol), indicating room-temperature reactivity. Dehydroisolongifolene exhibits the lowest RAF barrier (14 kJ/mol) and exceptional multi-mechanism performance, making it the top candidate for experimental validation. (+)-Carotol shows balanced activity across multiple mechanisms, ideal for broad-spectrum applications, while (-)-myrtenol demonstrates the best RAF performance among monoterpenoids. Sesquiterpenoids outperform monoterpenoids in electron transfer due to enhanced π-conjugation, whereas monoterpenoids excel in radical addition kinetics. Oxygen functionalization, conjugation extent, and site accessibility are key determinants of antioxidant capacity. These computational predictions provide a rational basis for prioritizing dehydroisolongifolene, (+)-carotol, and (-)-myrtenol in bioassay-guided fractionation, accelerating the discovery of novel antioxidants for burn wound healing, neuroprotection, and oxidative stress management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.